160 related articles for article (PubMed ID: 1653310)
1. Effects of recombinant human tumor necrosis factor on rodent gliomas and normal brain.
Kiwit JC; Schmitz KH; Daum L; Reifenberger G; Roosen N
J Neurosurg; 1991 Oct; 75(4):597-603. PubMed ID: 1653310
[TBL] [Abstract][Full Text] [Related]
2. The effect of combining recombinant human tumor necrosis factor-alpha with local radiation on tumor control probability of a human glioblastoma multiforme xenograft in nude mice.
Huang P; Allam A; Perez LA; Taghian A; Freeman J; Suit HD
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):93-8. PubMed ID: 7721643
[TBL] [Abstract][Full Text] [Related]
3. Effects of an intratumoral injection of human recombinant tumor necrosis factor-alpha on cerebrovascular permeability and leukocytic infiltration in a rat glioma model.
Wright JL; Merchant RE
Acta Neuropathol; 1997 Jan; 93(1):78-86. PubMed ID: 9006660
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of recombinant human tumor necrosis factor-alpha in rats. Effects of size and number of doses and nephrectomy.
Ferraiolo BL; McCabe J; Hollenbach S; Hultgren B; Pitti R; Wilking H
Drug Metab Dispos; 1989; 17(4):369-72. PubMed ID: 2571474
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model.
Kido G; Wright JL; Merchant RE
J Neurooncol; 1991 Apr; 10(2):95-109. PubMed ID: 1716671
[TBL] [Abstract][Full Text] [Related]
6. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
Gridley DS; Slater JM; Stickney DR
J Biol Response Mod; 1989 Dec; 8(6):593-602. PubMed ID: 2513378
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
Palladino MA; Shalaby MR; Kramer SM; Ferraiolo BL; Baughman RA; Deleo AB; Crase D; Marafino B; Aggarwal BB; Figari IS
J Immunol; 1987 Jun; 138(11):4023-32. PubMed ID: 3295044
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the growth of transformed cells by human tumor necrosis factor-alpha and interferon-gamma.
Lewis GD; Aggarwal BB; Eessalu TE; Sugarman BJ; Shepard HM
Cancer Res; 1987 Oct; 47(20):5382-5. PubMed ID: 2820567
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor alpha in rats.
Debs RJ; Fuchs HJ; Philip R; Brunette EN; Düzgüneş N; Shellito JE; Liggitt D; Patton JR
Cancer Res; 1990 Jan; 50(2):375-80. PubMed ID: 2295077
[TBL] [Abstract][Full Text] [Related]
10. Effects of intracarotid and intravenous infusion of human TNF and LT on established intracerebral rat gliomas.
Liu SK; Jakowatz JG; Pollack RB; Ceraldi C; Yamamoto R; Dett C; Lopez F; Camacho C; Carson WE; Sentovich SM
Lymphokine Cytokine Res; 1991 Jun; 10(3):189-94. PubMed ID: 1883913
[TBL] [Abstract][Full Text] [Related]
11. Effects of growth factors on the antiproliferative activity of tumor necrosis factors.
Sugarman BJ; Lewis GD; Eessalu TE; Aggarwal BB; Shepard HM
Cancer Res; 1987 Feb; 47(3):780-6. PubMed ID: 3802082
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
Ferraiolo BL; Moore JA; Crase D; Gribling P; Wilking H; Baughman RA
Drug Metab Dispos; 1988; 16(2):270-5. PubMed ID: 2898346
[TBL] [Abstract][Full Text] [Related]
13. Cryosurgery and rhTNF-α play synergistic effects on a rat cortex C6 glioma model.
Huang KM; Peng M; Feng YQ; Huang H; Tu HJ; Luo J; Zhang L; Yuan XH; Wang LC
Cryobiology; 2012 Feb; 64(1):43-9. PubMed ID: 21982953
[TBL] [Abstract][Full Text] [Related]
14. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
Pollack IF; Erff M; Ashkenazi A
Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
[TBL] [Abstract][Full Text] [Related]
16. PEGylated recombinant human tumor necrosis factor alpha: preparation and anti-tumor potency.
Li YP; Pei YY; Ding J; Shen ZM; Zhang XY; Gu ZH; Zhou JJ
Acta Pharmacol Sin; 2001 Jun; 22(6):549-55. PubMed ID: 11747763
[TBL] [Abstract][Full Text] [Related]
17. Intracarotid recombinant human tumor necrosis factor-alpha reduces cerebral blood flow and methionine uptake in rat brain tumors.
Sasajima T; Mineura K; Kowada M; Hatazawa J; Miura S
J Neurooncol; 1997 Sep; 34(2):123-9. PubMed ID: 9210058
[TBL] [Abstract][Full Text] [Related]
18. PEGylated recombinant human tumor necrosis factor alpha: pharmacokinetics and anti-tumor effects.
Li YP; Pei YY; Zhou ZH; Zhang XY; Gu ZH; Ding J; Gao XJ; Zhu JH
Biol Pharm Bull; 2001 Jun; 24(6):666-70. PubMed ID: 11411556
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha enhances antitumor effects of radiation against glioma xenografts.
Gridley DS; Archambeau JO; Andres MA; Mao XW; Wright K; Slater JM
Oncol Res; 1997; 9(5):217-27. PubMed ID: 9306429
[TBL] [Abstract][Full Text] [Related]
20. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
